Enveda Announces Oversubscribed Series B1 Bringing Total Round to US$119 M
20 Apr 2023 //
BUSINESSWIRE
The Last Clinic Visit Conducted in Promore Pharma`s PII Study of Ensereptide
13 Jun 2022 //
ACCESSWIRE
20 Apr 2023 //
BUSINESSWIRE
13 Jun 2022 //
ACCESSWIRE